N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C125H119F15N30O8 — CID 165091489

IUPACN-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-c4ccccn4)cc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cc(C#N)cn4)cc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)C1.CC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)CC1.CC1(O)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)CC1
InChIInChI=1S/C27H26F3N5O.C25H22F3N7O2.C25H25F3N6O.2C24H23F3N6O2/c1-26(2,3)17-12-18(13-17)35-15-16-11-23(19(14-22(16)34-35)20-7-4-5-10-31-20)33-25(36)21-8-6-9-24(32-21)27(28,29)30;1-24(2,37)16-7-17(8-16)34-13-15-6-20(21(9-19(15)33-34)35-12-14(10-29)11-30-35)32-23(36)18-4-3-5-22(31-18)25(26,27)28;1-24(2)9-7-17(8-10-24)34-15-16-13-20(21(14-19(16)32-34)33-12-4-11-29-33)31-23(35)18-5-3-6-22(30-18)25(26,27)28;1-23(2,35)15-10-16(11-15)33-13-14-9-19(20(12-18(14)31-33)32-8-4-7-28-32)30-22(34)17-5-3-6-21(29-17)24(25,26)27;1-23(35)8-6-16(7-9-23)33-14-15-12-19(20(13-18(15)31-33)32-11-3-10-28-32)30-22(34)17-4-2-5-21(29-17)24(25,26)27/h4-11,14-15,17-18H,12-13H2,1-3H3,(H,33,36);3-6,9,11-13,16-17,37H,7-8H2,1-2H3,(H,32,36);3-6,11-15,17H,7-10H2,1-2H3,(H,31,35);3-9,12-13,15-16,35H,10-11H2,1-2H3,(H,30,34);2-5,10-14,16,35H,6-9H2,1H3,(H,30,34)
InChIKeyWTZGDIJIISNLLT-UHFFFAOYSA-N
MW2454.50 g/mol
LogP26.64
Rot. Bonds22

About N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 165091489) has the molecular formula C125H119F15N30O8 and a molecular weight of 2454.50 g/mol. Its IUPAC name is N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID165091489
Molecular FormulaC125H119F15N30O8
Molecular Weight2454.50 g/mol
Exact Mass2452.96
IUPAC NameN-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-c4ccccn4)cc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cc(C#N)cn4)cc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)C1.CC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)CC1.CC1(O)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)CC1
InChIInChI=1S/C27H26F3N5O.C25H22F3N7O2.C25H25F3N6O.2C24H23F3N6O2/c1-26(2,3)17-12-18(13-17)35-15-16-11-23(19(14-22(16)34-35)20-7-4-5-10-31-20)33-25(36)21-8-6-9-24(32-21)27(28,29)30;1-24(2,37)16-7-17(8-16)34-13-15-6-20(21(9-19(15)33-34)35-12-14(10-29)11-30-35)32-23(36)18-4-3-5-22(31-18)25(26,27)28;1-24(2)9-7-17(8-10-24)34-15-16-13-20(21(14-19(16)32-34)33-12-4-11-29-33)31-23(35)18-5-3-6-22(30-18)25(26,27)28;1-23(2,35)15-10-16(11-15)33-13-14-9-19(20(12-18(14)31-33)32-8-4-7-28-32)30-22(34)17-5-3-6-21(29-17)24(25,26)27;1-23(35)8-6-16(7-9-23)33-14-15-12-19(20(13-18(15)31-33)32-11-3-10-28-32)30-22(34)17-4-2-5-21(29-17)24(25,26)27/h4-11,14-15,17-18H,12-13H2,1-3H3,(H,33,36);3-6,9,11-13,16-17,37H,7-8H2,1-2H3,(H,32,36);3-6,11-15,17H,7-10H2,1-2H3,(H,31,35);3-9,12-13,15-16,35H,10-11H2,1-2H3,(H,30,34);2-5,10-14,16,35H,6-9H2,1H3,(H,30,34)
InChIKeyWTZGDIJIISNLLT-UHFFFAOYSA-N
XLogP26.64
TPSA467.70 Ų
H-Bond Donors8
H-Bond Acceptors33
Rotatable Bonds22
Heavy Atoms178
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002454.50
LogP ≤ 526.64
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1033

Analyze N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-[2-[(1S)-1-[2-(3-acetylindazol-1-yl)butanoylamino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;3-[2-[(1S)-1-[[2-(4,6-difluoroindol-1-yl)acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-N-methylbenzamide;(4R)-1-[3-(difluoromethyl)-4,4,7,7-tetrafluoro-5,6-dihydroindazol-1-yl]-5-(3,5-difluorophenyl)-4-[3-(2-methylidene-1,3-dihydroindol-5-yl)-2-pyridinyl]pentan-2-one;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[2-(5-methylindol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[2-(6-methylindol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide
CID 159008446
6-(1,1-difluoroethyl)-3-[2,6-dimethyl-1-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperidin-4-yl]-1H-benzimidazol-2-one;6-(1,1-difluoroethyl)-3-[(2R,4S)-2-methyl-1-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperidin-4-yl]-1H-benzimidazol-2-one;6-(1,1-difluoroethyl)-3-[2,3,5,6-tetramethyl-4-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperazin-1-yl]-1,3-dihydroindol-2-one
CID 160191732
6-(1,1-difluoroethyl)-3-[(3S)-3,5-dimethyl-4-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperazin-1-yl]-1,3-dihydroindol-2-one;6-(1,1-difluoroethyl)-3-[(3R)-3,5-dimethyl-4-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperazin-1-yl]-1,3-dihydroindol-2-one;6-(1,1-difluoroethyl)-3-[(3R)-3-methyl-4-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperazin-1-yl]-1,3-dihydroindol-2-one;6-(1,1-difluoroethyl)-3-[3-methyl-4-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperazin-1-yl]-1,3-dihydroindol-2-one;6-methyl-3-[4-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]piperazin-1-yl]-1,3-dihydroindol-2-one;1'-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]spiro[1H-indene-3,4'-piperidine]-2-one
CID 161803237
N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;2-(3-methylcyclobutyl)propan-2-ol;N-(6-pyrazol-1-yl-1H-indazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide
CID 165017193
1-(5-amino-1H-indazol-6-yl)pyrazole-4-carbonitrile;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-1H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;6-fluoro-5-nitro-1H-indazole;2-(3-methylcyclobutyl)propan-2-ol;1-(5-nitro-1H-indazol-6-yl)pyrazole-4-carbonitrile;1H-pyrazole-4-carbonitrile;6-(trifluoromethyl)pyridine-2-carboxylic acid
CID 165033592
N-[6-acetyl-2-[(1S,4S)-3-[(2S,5S)-5-[4-[6-(3-cyanopyrrolo[1,2-b]pyridazin-7-yl)-4-(propan-2-ylamino)-3-pyridinyl]triazol-1-yl]-2-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperazin-1-yl]methyl]cyclohexyl]-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperazin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 167156424
N-[2-[(1R,4R)-4-[[4-[3-cyclopropyl-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]piperazin-1-yl]methyl]-3-[(2R,5R)-2-[[(1S,4S)-5-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]-5-[6-methyl-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 167156493
6-(3-cyanopyrrolo[1,2-b]pyridazin-7-yl)-N-[(1S,4S)-3-[(2S,5S)-5-[6-cyano-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]-2-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperazin-1-yl]methyl]cyclohexyl]-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperazin-1-yl]methyl]cyclohexyl]-4-(propan-2-ylamino)pyridine-3-carboxamide
CID 167156548
N-[2-[(1R,4R)-4-[[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,6-diazabicyclo[3.1.1]heptan-6-yl]methyl]-3-[(2R,5R)-2-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperazin-1-yl]methyl]-5-[6-propan-2-yl-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 167156731
6-(1,1-difluoroethyl)-N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-1-oxidopyridin-1-ium-2-carboxamide;6-(difluoromethyl)-N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-1-oxidopyridin-1-ium-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-1-oxidoquinolin-1-ium-2-carboxamide
CID 167692960
6-cyclopropyl-N-[2-(4-hydroxycyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-1-oxidopyridin-1-ium-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-1-oxido-6-propan-2-ylpyridin-1-ium-2-carboxamide
CID 167531992
6-cyclopropyl-N-[6-(dimethylamino)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-1-oxidopyridin-1-ium-2-carboxamide;N-[6-(dimethylamino)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-methyl-1-oxidopyridin-1-ium-2-carboxamide;N-[6-(dimethylamino)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-1-oxido-6-propan-2-ylpyridin-1-ium-2-carboxamide
CID 167581510

Frequently Asked Questions

What is the IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 165091489) is N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is CC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-c4ccccn4)cc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cc(C#N)cn4)cc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)C1.CC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)CC1.CC1(O)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(-n4cccn4)cc3n2)CC1.
What is the InChIKey of N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is WTZGDIJIISNLLT-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H26F3N5O.C25H22F3N7O2.C25H25F3N6O.2C24H23F3N6O2/c1-26(2,3)17-12-18(13-17)35-15-16-11-23(19(14-22(16)34-35)20-7-4-5-10-31-20)33-25(36)21-8-6-9-24(32-21)27(28,29)30;1-24(2,37)16-7-17(8-16)34-13-15-6-20(21(9-19(15)33-34)35-12-14(10-29)11-30-35)32-23(36)18-4-3-5-22(31-18)25(26,27)28;1-24(2)9-7-17(8-10-24)34-15-16-13-20(21(14-19(16)32-34)33-12-4-11-29-33)31-23(35)18-5-3-6-22(30-18)25(26,27)28;1-23(2,35)15-10-16(11-15)33-13-14-9-19(20(12-18(14)31-33)32-8-4-7-28-32)30-22(34)17-5-3-6-21(29-17)24(25,26)27;1-23(35)8-6-16(7-9-23)33-14-15-12-19(20(13-18(15)31-33)32-11-3-10-28-32)30-22(34)17-4-2-5-21(29-17)24(25,26)27/h4-11,14-15,17-18H,12-13H2,1-3H3,(H,33,36);3-6,9,11-13,16-17,37H,7-8H2,1-2H3,(H,32,36);3-6,11-15,17H,7-10H2,1-2H3,(H,31,35);3-9,12-13,15-16,35H,10-11H2,1-2H3,(H,30,34);2-5,10-14,16,35H,6-9H2,1H3,(H,30,34).
What are the key properties of N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 2454.50 g/mol, XLogP of 26.64, 22 rotatable bonds, 8 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-tert-butylcyclobutyl)-6-pyridin-2-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(4-cyanopyrazol-1-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-pyrazol-1-ylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 165091489), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).